{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:11:11Z","timestamp":1779167471242,"version":"3.51.4"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903902"],"award-info":[{"award-number":["81903902"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023NSFSC0684"],"award-info":[{"award-number":["2023NSFSC0684"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2025ZNSFSC1806"],"award-info":[{"award-number":["2025ZNSFSC1806"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["QJRC2022053"],"award-info":[{"award-number":["QJRC2022053"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chengdu Health Commission - Chengdu University of Traditional Chinese Medicine Joint Innovation Fund","award":["WXLH202501013"],"award-info":[{"award-number":["WXLH202501013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00769-5","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:25:00Z","timestamp":1776147900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel genetic insights into causal effects of potential metformin targets and immune mediation on sepsis"],"prefix":"10.1186","volume":"21","author":[{"given":"Li","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"21","key":"769_CR1","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.3390\/ijms20215376","volume":"20","author":"M Huang","year":"2019","unstructured":"Huang M, Cai SL, Su JQ. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol. 2019;20(21):5376.","journal-title":"Int J Mol"},{"issue":"1","key":"769_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in europe and north america: A systematic review and meta-analysis. Crit Care. 2019;23(1):196.","journal-title":"Crit Care"},{"issue":"1","key":"769_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in europe, north america and australia between 2009 and 2019-results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239.","journal-title":"Crit Care"},{"key":"769_CR4","doi-asserted-by":"crossref","unstructured":"Vincent JL. Current sepsis therapeutics. eBioMedicine. 2022; 86:104318.","DOI":"10.1016\/j.ebiom.2022.104318"},{"issue":"11","key":"769_CR5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1007\/s00134-023-07239-w","volume":"49","author":"RBE van Amstel","year":"2023","unstructured":"van Amstel RBE, Kennedy JN, Scicluna BP, et al. Uncovering heterogeneity in sepsis: A comparative analysis of subphenotypes. Intensive Care Med. 2023;49(11):1360\u20139.","journal-title":"Intensive Care Med"},{"key":"769_CR6","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.2147\/JIR.S460413","volume":"17","author":"SY Fan","year":"2024","unstructured":"Fan SY, Zhao ZC, Liu XL, et al. Metformin mitigates sepsis-induced acute lung injury and inflammation in young mice by suppressing the S100A8\/A9-NLRP3-IL-1\u03b2 signaling pathway. J Inflamm Res. 2024;17:3785\u201399.","journal-title":"J Inflamm Res"},{"issue":"1","key":"769_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/22221751.2022.2045876","volume":"11","author":"HY Liang","year":"2022","unstructured":"Liang HY, Song H, Zhang XJ, et al. Metformin attenuated sepsis-related liver injury by modulating gut microbiota. Emerg Microbes Infect. 2022;11(1):815\u201328.","journal-title":"Emerg Microbes Infect"},{"key":"769_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2015.12.030","volume":"772","author":"H Vaez","year":"2016","unstructured":"Vaez H, Rameshrad M, Najafi M, Barar J, Barzegari A, Garjani A. Cardioprotective effect of metformin in lipopolysaccharide-induced sepsis via suppression of toll-like receptor 4 (TLR4) in heart. Eur J Pharmacol. 2016;772:115\u201323.","journal-title":"Eur J Pharmacol"},{"key":"769_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-physiol-061121-040214","volume":"84","author":"LK Torres","year":"2022","unstructured":"Torres LK, Pickkers P, van der Poll T. Sepsis-induced immunosuppression. Annu Rev Physiol. 2022;84:157\u201381.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"769_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: Time for a reappraisal. Crit Care. 2020;24(1):287.","journal-title":"Crit Care"},{"issue":"1","key":"769_CR11","doi-asserted-by":"publisher","first-page":"e1170","DOI":"10.1002\/ctm2.1170","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Wang YHZ, Qu MD, et al. Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis. Clin Transl Med. 2023;13(1):e1170.","journal-title":"Clin Transl Med"},{"issue":"2","key":"769_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14(2):121\u201337.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"769_CR13","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ymthe.2021.12.013","volume":"30","author":"SY Huang","year":"2022","unstructured":"Huang SY, Liu D, Sun JH, et al. Tim-3 regulates sepsis-induced immunosuppression by inhibiting the NF-\u03baB signaling pathway in CD4 T cells. Mol Ther. 2022;30(3):1227\u201338.","journal-title":"Mol Ther"},{"issue":"9","key":"769_CR14","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41551-023-01050-0","volume":"7","author":"DP Schrijver","year":"2023","unstructured":"Schrijver DP, R\u00f6ring RJ, Deckers J, et al. Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells. Nat Biomed Eng. 2023;7(9):1097\u2013112.","journal-title":"Nat Biomed Eng"},{"issue":"2","key":"769_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00011-023-01827-8","volume":"73","author":"ZY Wang","year":"2024","unstructured":"Wang ZY, Wang M, Lin M, Wei P. The immunomodulatory effects of metformin in LPS-induced macrophages: An in vitro study. Inflamm Res. 2024;73(2):175\u201381.","journal-title":"Inflamm Res"},{"issue":"1","key":"769_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-019-0695-y","volume":"19","author":"G Prada-Ramallal","year":"2019","unstructured":"Prada-Ramallal G, Takkouche B, Figueiras A. Bias in pharmacoepidemiologic studies using secondary health care databases: A scoping review. BMC Med Res Methodol. 2019;19(1):53.","journal-title":"BMC Med Res Methodol"},{"key":"769_CR17","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Smith GD. Reading mendelian randomisation studies: A guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.","journal-title":"BMJ"},{"issue":"R1","key":"769_CR18","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: Genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89\u201398.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"769_CR19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","volume":"2","author":"L Folkersen","year":"2020","unstructured":"Folkersen L, Gustafsson S, Wang Q, et al. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals. Nat Metab. 2020;2(10):1135\u201348.","journal-title":"Nat Metab"},{"issue":"1","key":"769_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. Mendelian randomization\u2019: Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"9","key":"769_CR21","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1055-9965.EPI-17-1177","volume":"27","author":"J Yarmolinsky","year":"2018","unstructured":"Yarmolinsky J, Wade KH, Richmond RC, et al. Causal inference in cancer epidemiology: What is the role of mendelian randomization? Cancer Epidemiol Biomarkers Prev. 2018;27(9):995\u20131010.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"769_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.12688\/wellcomeopenres.16544.1","volume":"6","author":"D Gill","year":"2021","unstructured":"Gill D, Georgakis MK, Walker VM, et al. Mendelian randomization for studying the effects of perturbing drug targets. Wellcome Open Res. 2021;6:16.","journal-title":"Wellcome Open Res"},{"issue":"15","key":"769_CR23","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","volume":"65","author":"BA Ference","year":"2015","unstructured":"Ference BA, Majeed F, Penumetcha R, Flack JM, Brook RD. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2\u00d72 factorial Mendelian randomization study. J Am Coll Cardiol. 2015;65(15):1552\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"9965","key":"769_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","volume":"385","author":"DI Swerdlow","year":"2015","unstructured":"Swerdlow DI, Preiss D, Kuchenbaecker KB, et al. HMG-coenzyme a reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials. Lancet. 2015;385(9965):351\u201361.","journal-title":"Lancet"},{"issue":"22","key":"769_CR25","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","volume":"375","author":"BA Ference","year":"2016","unstructured":"Ference BA, Robinson JG, Brook RD, et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N Engl J Med. 2016;375(22):2144\u201353.","journal-title":"N Engl J Med"},{"issue":"9","key":"769_CR26","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s00125-019-4913-2","volume":"62","author":"SLA Yeung","year":"2019","unstructured":"Yeung SLA, Luo S, Schooling CM. The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: A mendelian randomisation study. Diabetologia. 2019;62(9):1638\u201346.","journal-title":"Diabetologia"},{"issue":"10","key":"769_CR27","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","volume":"65","author":"J Zheng","year":"2022","unstructured":"Zheng J, Xu M, Walker V, et al. Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: A mendelian randomisation study. Diabetologia. 2022;65(10):1664\u201375.","journal-title":"Diabetologia"},{"issue":"3","key":"769_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.taap.2009.11.026","volume":"243","author":"MP Quaile","year":"2010","unstructured":"Quaile MP, Melich DH, Jordan HL, et al. Toxicity and toxicokinetics of metformin in rats. Toxicol Appl Pharmacol. 2010;243(3):340\u20137.","journal-title":"Toxicol Appl Pharmacol"},{"key":"769_CR29","first-page":"193","volume":"31","author":"P Yu","year":"2023","unstructured":"Yu P, Lin B, Li JY, et al. Noninvasive intratracheal lipopolysaccharide instillation in mice. Jove-J Vis Exp. 2023;31:193.","journal-title":"Jove-J Vis Exp"},{"issue":"6","key":"769_CR30","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/CCM.0000000000005468","volume":"50","author":"H G\u00f3mez","year":"2022","unstructured":"G\u00f3mez H, Del Rio-Pertuz G, Priyanka P, et al. Association of metformin use during hospitalization and mortality in critically ill adults with type 2 diabetes mellitus and sepsis. Crit Care Med. 2022;50(6):935\u201344.","journal-title":"Crit Care Med"},{"key":"769_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13054-015-1180-6","volume":"20","author":"K Doenyas-Barak","year":"2016","unstructured":"Doenyas-Barak K, Beberashvili I, Marcus R, Efrati S. Lactic acidosis and severe septic shock in metformin users: A cohort study. Crit Care. 2016;20:10.","journal-title":"Crit Care"},{"issue":"1","key":"769_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13054-019-2346-4","volume":"23","author":"HY Liang","year":"2019","unstructured":"Liang HY, Ding XF, Li LF, et al. Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: A systematic review and meta-analysis of cohort studies. Crit Care. 2019;23(1):50.","journal-title":"Crit Care"},{"issue":"7","key":"769_CR33","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/j.1476-5381.2010.01126.x","volume":"162","author":"K Tsoyi","year":"2011","unstructured":"Tsoyi K, Jang HJ, Nizamutdinova IT, et al. Metformin inhibits HMGB1 release in LPS-treated RAW 264.7 cells and increases survival rate of endotoxaemic mice. Br J Pharmacol. 2011;162(7):1498\u2013508.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"769_CR34","doi-asserted-by":"publisher","first-page":"937","DOI":"10.2119\/molmed.2015.00198","volume":"21","author":"ZY Liu","year":"2016","unstructured":"Liu ZY, Bone N, Jiang SN, et al. AMP-activated protein kinase and glycogen synthase kinase 3\u03b2 modulate the severity of sepsis-induced lung injury. Mol Med. 2016;21(1):937\u201350.","journal-title":"Mol Med"},{"issue":"5","key":"769_CR35","first-page":"469","volume":"21","author":"H Ghavimi","year":"2018","unstructured":"Ghavimi H, Sheidaei S, Vaez H, Zolali E, Asgharian P, Hamishehkar H. Metformin-attenuated sepsis-induced oxidative damages: A novel role for metformin. Iran J Basic Med Sci. 2018;21(5):469\u201375.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"769_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12868-021-00683-8","volume":"22","author":"ZH Qin","year":"2021","unstructured":"Qin ZH, Zhou CL, Xiao XC, Guo CP. Metformin attenuates sepsis-induced neuronal injury and cognitive impairment. BMC Neurosci. 2021;22(1):78.","journal-title":"BMC Neurosci"},{"issue":"3","key":"769_CR37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","volume":"89","author":"GR Steinberg","year":"2009","unstructured":"Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev. 2009;89(3):1025\u201378.","journal-title":"Physiol Rev"},{"issue":"1","key":"769_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2014.03.002","volume":"20","author":"K Burkewitz","year":"2014","unstructured":"Burkewitz K, Zhang Y, Mair WB. AMPK at the nexus of energetics and aging. Cell Metab. 2014;20(1):10\u201325.","journal-title":"Cell Metab"},{"issue":"7899","key":"769_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41586-022-04431-8","volume":"603","author":"T Ma","year":"2022","unstructured":"Ma T, Tian X, Zhang BD, et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603(7899):159\u201365.","journal-title":"Nature"},{"issue":"12","key":"769_CR40","doi-asserted-by":"publisher","first-page":"14010","DOI":"10.1096\/fj.201901820R","volume":"33","author":"H Shamshoum","year":"2019","unstructured":"Shamshoum H, Medak KD, Townsend LK, et al. AMPK \u03b21 activation suppresses antipsychotic-induced hyperglycemia in mice. FASEB J. 2019;33(12):14010\u201321.","journal-title":"FASEB J"},{"issue":"3","key":"769_CR41","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41419-021-03536-8","volume":"12","author":"Z Zheng","year":"2021","unstructured":"Zheng Z, Li Y, Fan SY, et al. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPK\u03b21. Cell Death Dis. 2021;12(3):228.","journal-title":"Cell Death Dis"},{"issue":"5","key":"769_CR42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/SHK.0000000000001303","volume":"52","author":"L Kitzmiller","year":"2019","unstructured":"Kitzmiller L, Ledford JR, Hake PW, O\u2019Connor M, Piraino G, Zingarelli B. Activation of AMP-activated protein kinase by A769662 ameliorates sepsis-induced acute lung injury in adult mice. Shock. 2019;52(5):540\u20139.","journal-title":"Shock"},{"issue":"12","key":"769_CR43","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, et al. Current gaps in sepsis immunology: New opportunities for translational research. Lancet Infect Dis. 2019;19(12):e422\u201336.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"769_CR44","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","volume":"54","author":"T van der Poll","year":"2021","unstructured":"van der Poll T, Shankar-Hari M, Wiersinga WJ. The immunology of sepsis. Immunity. 2021;54(11):2450\u201364.","journal-title":"Immunity"},{"issue":"8","key":"769_CR45","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/jnci\/djae070","volume":"116","author":"CWF van Eijck","year":"2024","unstructured":"van Eijck CWF, Vadgama D, van Eijck CHJ, Wilmink JW. Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: An observational study. J Natl Cancer Inst. 2024;116(8):1374\u201383.","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"769_CR46","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1158\/1078-0432.CCR-20-0113","volume":"26","author":"SH Wang","year":"2020","unstructured":"Wang SH, Lin YS, Xiong X, et al. Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: Results of a phase \u2161 clinical trial. Clin Cancer Res. 2020;26(18):4921\u201332.","journal-title":"Clin Cancer Res"},{"key":"769_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ebiom.2017.10.009","volume":"25","author":"Y Kunisada","year":"2017","unstructured":"Kunisada Y, Eikawa S, Tomonobu N, et al. Attenuation of CD4+ CD25+ regulatory T cells in the tumor microenvironment by metformin, a type 2 diabetes drug. eBioMedicine. 2017;25:154\u201364.","journal-title":"eBioMedicine"},{"issue":"8","key":"769_CR48","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/s41423-022-00894-x","volume":"19","author":"XF Mu","year":"2022","unstructured":"Mu XF, Xiang Z, Xu Y, et al. Glucose metabolism controls human \u03b3\u03b4 T-cell-mediated tumor immunosurveillance in diabetes. Cell Mol Immunol. 2022;19(8):944\u201356.","journal-title":"Cell Mol Immunol"},{"issue":"30","key":"769_CR49","doi-asserted-by":"publisher","first-page":"e2404778121","DOI":"10.1073\/pnas.2404778121","volume":"121","author":"M Tokumasu","year":"2024","unstructured":"Tokumasu M, Nishida M, Zhao WY, et al. Metformin synergizes with PD-1 blockade to promote normalization of tumor vessels via CD8 T cells and IFN\u03b3. Proc Natl Acad Sci U S A. 2024;121(30):e2404778121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"769_CR50","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","volume":"77","author":"S Wabitsch","year":"2022","unstructured":"Wabitsch S, McCallen JD, Kamenyeva O, et al. Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD. J Hepatol. 2022;77(3):748\u201360.","journal-title":"J Hepatol"},{"issue":"14","key":"769_CR51","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","volume":"83","author":"XW Huang","year":"2023","unstructured":"Huang XW, Sun TT, Wang JL, et al. Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer. Cancer Res. 2023;83(14):2358\u201371.","journal-title":"Cancer Res"},{"issue":"4","key":"769_CR52","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","volume":"71","author":"JH Cha","year":"2018","unstructured":"Cha JH, Yang WH, Xia WY, et al. Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1. Mol Cell. 2018;71(4):606\u2013e6207.","journal-title":"Mol Cell"},{"issue":"11","key":"769_CR53","doi-asserted-by":"publisher","first-page":"e005632","DOI":"10.1136\/jitc-2022-005632","volume":"10","author":"M Crist","year":"2022","unstructured":"Crist M, Yaniv B, Palackdharry S, et al. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition. J Immunother Cancer. 2022;10(11):e005632.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"769_CR54","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.humimm.2018.07.002","volume":"79","author":"YJ Fu","year":"2018","unstructured":"Fu YJ, Zhang JH, Bai HS, Chen YZ, Liu RP, Bai N. Genetic association between CD86 polymorphisms and the risk of sepsis in a chinese Han population. Hum Immunol. 2018;79(11):817\u201320.","journal-title":"Hum Immunol"},{"key":"769_CR55","doi-asserted-by":"crossref","unstructured":"Khamri W, Abeles RD, Hou TZ et al. Increased expression of cytotoxic T-lymphocyte-associated protein 4 by T cells, induced by B7 in sera, reduces adaptive immunity in patients with acute liver failure. Gastroenterology. 2017; 153(1): 263\u2009\u2013 76.e8.","DOI":"10.1053\/j.gastro.2017.03.023"},{"issue":"21","key":"769_CR56","doi-asserted-by":"publisher","first-page":"e70178","DOI":"10.1111\/jcmm.70178","volume":"28","author":"F Chen","year":"2024","unstructured":"Chen F, Wang N, Liao J, et al. Esculetin rebalances m1\/m2 macrophage polarization to treat sepsis-induced acute lung injury through regulating metabolic reprogramming. J Cell Mol Med. 2024;28(21):e70178.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"769_CR57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1164\/rccm.200703-515OC","volume":"177","author":"A Nolan","year":"2008","unstructured":"Nolan A, Weiden M, Kelly A, et al. CD40 and CD80\/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis. Am J Respir Crit Care Med. 2008;177(3):301\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"769_CR58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/infdis\/jiz158","volume":"220","author":"YY Luan","year":"2019","unstructured":"Luan YY, Zhang L, Zhu FJ, Dong N, Lu JY, Yao YM. Effect of TIPE1 on immune function of dendritic cells and its signaling pathway in septic mice. J Infect Dis. 2019;220(4):699\u2013709.","journal-title":"J Infect Dis"},{"issue":"1","key":"769_CR59","doi-asserted-by":"publisher","first-page":"2367659","DOI":"10.1080\/21505594.2024.2367659","volume":"15","author":"X Yuan","year":"2024","unstructured":"Yuan X, Song XL, Zhang X, et al. Unraveling host-pathogen dynamics in a murine model of septic peritonitis induced by vancomycin-resistant enterococcus faecium. Virulence. 2024;15(1):2367659.","journal-title":"Virulence"},{"issue":"1","key":"769_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40560-025-00784-0","volume":"13","author":"H Li","year":"2025","unstructured":"Li H, Ding P, Nan Y, et al. Low expression of CD39 on monocytes predicts poor survival in sepsis patients. J Intensive Care. 2025;13(1):12.","journal-title":"J Intensive Care"},{"key":"769_CR61","doi-asserted-by":"publisher","first-page":"114445","DOI":"10.1016\/j.intimp.2025.114445","volume":"153","author":"Y Ji","year":"2025","unstructured":"Ji Y, Wang C, Wang B, et al. Low levels of CD39+ tregs may predict poor outcome in children with sepsis. Int Immunopharmacol. 2025;153:114445.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"769_CR62","doi-asserted-by":"publisher","first-page":"R172","DOI":"10.1186\/cc8148","volume":"13","author":"A Pelekanou","year":"2009","unstructured":"Pelekanou A, Tsangaris I, Kotsaki A, et al. Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: Results from an observational study. Crit Care. 2009;13(6):R172.","journal-title":"Crit Care"},{"issue":"10","key":"769_CR63","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1182\/blood-2007-04-087171","volume":"110","author":"PO Scumpia","year":"2007","unstructured":"Scumpia PO, Delano MJ, Kelly-Scumpia KM, et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 2007;110(10):3673\u201381.","journal-title":"Blood"},{"issue":"23","key":"769_CR64","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2011.1829","volume":"306","author":"JS Boomer","year":"2011","unstructured":"Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011;306(23):2594\u2013605.","journal-title":"JAMA"},{"key":"769_CR65","doi-asserted-by":"publisher","first-page":"e55800","DOI":"10.7554\/eLife.55800","volume":"9","author":"IJ Jensen","year":"2020","unstructured":"Jensen IJ, Jensen SN, Sjaastad FV, et al. Sepsis impedes eae disease development and diminishes autoantigen-specific naive CD4 T cells. Elife. 2020;9:e55800.","journal-title":"Elife"},{"issue":"7","key":"769_CR66","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/00003246-200107000-00021","volume":"29","author":"EF Yekebas","year":"2001","unstructured":"Yekebas EF, Eisenberger CF, Ohnesorge H, et al. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med. 2001;29(7):1423\u201330.","journal-title":"Crit Care Med"},{"issue":"1","key":"769_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-017-0546-x","volume":"8","author":"G Qiu","year":"2017","unstructured":"Qiu G, Zheng G, Ge M, et al. Adipose-derived mesenchymal stem cells modulate CD14++CD16+ expression on monocytes from sepsis patients in vitro via prostaglandin E2. Stem Cell Res Ther. 2017;8(1):97.","journal-title":"Stem Cell Res Ther"},{"key":"769_CR68","doi-asserted-by":"publisher","first-page":"e60849","DOI":"10.7554\/eLife.60849","volume":"9","author":"C Alarc\u00f3n-Vila","year":"2020","unstructured":"Alarc\u00f3n-Vila C, Baroja-Mazo A, de Torre-Minguela C, et al. CD14 release induced by P2X7 receptor restricts inflammation and increases survival during sepsis. Elife. 2020;9:e60849.","journal-title":"Elife"},{"issue":"2","key":"769_CR69","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jth.15162","volume":"19","author":"RS Keshari","year":"2021","unstructured":"Keshari RS, Silasi R, Popescu NI, et al. CD14 inhibition improves survival and attenuates thrombo-inflammation and cardiopulmonary dysfunction in a baboon model of Escherichia coli sepsis. J Thromb Haemost. 2021;19(2):429\u201343.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"769_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4062\/biomolther.2012.094","volume":"21","author":"S Shin","year":"2013","unstructured":"Shin S, Hyun B, Lee A, et al. Metformin suppresses MHC-restricted antigen presentation by inhibiting co-stimulatory factors and mhc molecules in APCs. Biomol Ther (Seoul). 2013;21(1):35\u201341.","journal-title":"Biomol Ther (Seoul)"},{"issue":"1","key":"769_CR71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbrc.2017.04.012","volume":"487","author":"Y Sharma","year":"2017","unstructured":"Sharma Y, Bashir S, Ansarullah, Khan MF, Ahmad A, Khan F. Inhibition of Src homology 2 domain containing protein tyrosine phosphatase as the possible mechanism of metformin-assisted amelioration of obesity induced insulin resistance in high fat diet fed C57BL\/6J mice. Biochem Biophys Res Commun. 2017;487(1):54\u201361.","journal-title":"Biochem Biophys Res Commun"},{"key":"769_CR72","doi-asserted-by":"crossref","unstructured":"Zhou Z, Tang Y, Jin X et al. Metformin inhibits advanced glycation end products-induced inflammatory response in murine macrophages partly through AMPK activation and RAGE\/NF\u03baB pathway suppression. J Diabetes Res. 2016; 2016: 4847812.","DOI":"10.1155\/2016\/4847812"},{"issue":"1","key":"769_CR73","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/01913123.2024.2440479","volume":"49","author":"MY Alshahrani","year":"2025","unstructured":"Alshahrani MY, Al Amri FS, Alzahrani MA, et al. Metformin ameliorates diabetes-induced hepatic ultrastructural damage and the immune biomarker CD86 and inflammation in rats. Ultrastruct Pathol. 2025;49(1):58\u201366.","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"769_CR74","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jhep.2017.05.021","volume":"67","author":"LEB Savio","year":"2017","unstructured":"Savio LEB, de Andrade Mello P, Figliuolo VR, et al. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury. J Hepatol. 2017;67(4):716\u201326.","journal-title":"J Hepatol"},{"issue":"5","key":"769_CR75","first-page":"1707","volume":"44","author":"M Yang","year":"2019","unstructured":"Yang M, Lu L, Kang Z, Ma T, Wang Y. Overexpressed CD39 mitigates sepsis\u2013induced kidney epithelial cell injury via suppressing the activation of NLR family pyrin domain containing 3. Int J Mol Med. 2019;44(5):1707\u201318.","journal-title":"Int J Mol Med"},{"issue":"4","key":"769_CR76","doi-asserted-by":"publisher","first-page":"e008053","DOI":"10.1136\/jitc-2023-008053","volume":"12","author":"R Turpin","year":"2024","unstructured":"Turpin R, Liu RX, Munne PM, et al. Respiratory complex \u2160 regulates dendritic cell maturation in explant model of human tumor immune microenvironment. J Immunother Cancer. 2024;12(4):e008053.","journal-title":"J Immunother Cancer"},{"key":"769_CR77","first-page":"391","volume":"14","author":"R Wang","year":"2022","unstructured":"Wang R, Li Y, Zhao Y, et al. Metformin inducing the change of functional and exhausted phenotypic tumor-infiltrated lymphocytes and the correlation with JNK signal pathway in Triple-negative breast cancer. Breast Cancer (Dove Med Press). 2022;14:391\u2013403.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"3","key":"769_CR78","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1530\/rep.1.00941","volume":"131","author":"V Sander","year":"2006","unstructured":"Sander V, Luchetti CG, Solano ME, et al. Role of the N, N\u2019-dimethylbiguanide metformin in the treatment of female prepuberal BALB\/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction. 2006;131(3):591\u2013602.","journal-title":"Reproduction"},{"issue":"1","key":"769_CR79","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12192-011-0282-6","volume":"17","author":"AC Tsuei","year":"2012","unstructured":"Tsuei AC, Martinus RD. Metformin induced expression of Hsp60 in human THP-1 monocyte cells. Cell Stress Chaperones. 2012;17(1):23\u20138.","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"769_CR80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.865444","volume":"121","author":"R Sofat","year":"2010","unstructured":"Sofat R, Hingorani AD, Smeeth L, et al. Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms. Circulation. 2010;121(1):52\u201362.","journal-title":"Circulation"},{"issue":"2","key":"769_CR81","doi-asserted-by":"publisher","first-page":"e1003897","DOI":"10.1371\/journal.pmed.1003897","volume":"19","author":"J Yarmolinsky","year":"2022","unstructured":"Yarmolinsky J, Diez-Obrero V, Richardson TM, et al. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis. PLoS Med. 2022;19(2):e1003897.","journal-title":"PLoS Med"},{"issue":"2","key":"769_CR82","doi-asserted-by":"publisher","first-page":"e1003898","DOI":"10.1371\/journal.pmed.1003898","volume":"19","author":"D Gill","year":"2022","unstructured":"Gill D, Burgess S. The evolution of mendelian randomization for investigating drug effects. PLoS Med. 2022;19(2):e1003898.","journal-title":"PLoS Med"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00769-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00769-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00769-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:31:02Z","timestamp":1779165062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00769-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00769-5","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our MR study used publicly available secondary data for analysis. Informed consent was obtained from all participants as per the original studies, and all ethical approvals were obtained by the original investigators. Therefore, this part of the study was exempt from institutional review board review. All animal experiments were approved by the Animal Ethics Committee of Chengdu University of Traditional Chinese Medicine (2024154).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}